ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients

ClinicalTrials.gov ID: NCT00002445

Public ClinicalTrials.gov record NCT00002445. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 1:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized Placebo Controlled and Double Blinded Study of IM862 for Patients With Muco-Cutaneous AIDS Associated Kaposi's Sarcoma

Study identification

NCT ID
NCT00002445
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cytran
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

  • IM862 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
31
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
AIDS Healthcare Foundation Los Angeles California 90027
LAGLC Los Angeles California 90028
USC School of Medicine / Norris Cancer Hosp Los Angeles California 90033
Tower ID Med Associates Los Angeles California 90048
UCLA Care Ctr Los Angeles California 90095
UCSD Med Ctr San Diego California 92103
UCSF - San Francisco Gen Hosp San Francisco California 94110
Conant Med Ctr San Francisco California 94117
Univ of Miami School of Medicine Miami Florida 331361013
BioQuan Research Group North Miami Florida 33161
Grady Mem Hosp Atlanta Georgia 30308
Northwestern Univ Chicago Illinois 60611
Infectious Disease of Indiana Indianapolis Indiana 46218
Johns Hopkins Oncology Baltimore Maryland 21231
Massachusetts Gen Hosp Boston Massachusetts 02114
Boston Med Ctr Boston Massachusetts 02118
Beth Israel Med Ctr Boston Massachusetts 02215
Washington Univ School of Medicine St Louis Missouri 63110
UMDNJ - New Jersey Med School Newark New Jersey 071032757
St Vincents Hosp / Clinical Research Program New York New York 10011
New York Univ Med Ctr New York New York 10016
Mem Sloan - Kettering Cancer Ctr New York New York 10021
Columbia-Presbyterian Hosp New York New York 10032
Albert Einstein Comprehensive Ctr The Bronx New York 10461
Case Western Reserve Univ Cleveland Ohio 44106
Ohio State Univ Columbus Ohio 43210
Pennsylvania Oncology and Hematology Associates Philadelphia Pennsylvania 19106
Vanderbilt Cancer Ctr Nashville Tennessee 37232
Cytran Inc Kirkland Washington 98033
Virginia Mason Med Ctr Seattle Washington 98101
Univ of Washington / Harborview Med Ctr Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002445, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002445 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →